Book chapter · 2020

Pharmacologic treatment of negative symptoms: Focus on efficacy

Pál Czobor, István Bitter

Oxford University Press eBooks, 67–86 · Published 1 March 2020 · DOI 10.1093/med/9780198840121.003.0005

View at the publisherCite this paper

In brief

“Pharmacologic treatment of negative symptoms: Focus on efficacy” is a 2020 book chapter by Pál Czobor and István Bitter, published in Oxford University Press eBooks. OpenAlex counts 17 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
17
Most cited in
2022 (4)
Field-weighted impact
9.36
Authors
2

Abstract

During the last decade negative symptoms in schizophrenia became a legitimate indication for potential drug targets. Significant progress has been made to improve measurement of negative symptoms, to distinguish between primary and secondary negative symptoms, and the importance of predominant negative symptoms was underlined. However, few clinical trials focused on primary and/or predominant negative symptoms.… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Czobor, P., & Bitter, I. (2020). Pharmacologic treatment of negative symptoms: Focus on efficacy. Oxford University Press eBooks, 67–86. https://doi.org/10.1093/med/9780198840121.003.0005

MLA 9

Czobor, Pál, and István Bitter. “Pharmacologic treatment of negative symptoms: Focus on efficacy.” Oxford University Press eBooks, 2020, pp. 67–86. https://doi.org/10.1093/med/9780198840121.003.0005.

Chicago

Czobor, Pál and István Bitter. 2020. “Pharmacologic treatment of negative symptoms: Focus on efficacy.” Oxford University Press eBooks: 67–86. https://doi.org/10.1093/med/9780198840121.003.0005.

Harvard

Czobor, P. and Bitter, I. (2020) ‘Pharmacologic treatment of negative symptoms: Focus on efficacy’, Oxford University Press eBooks, pp. 67–86. doi:10.1093/med/9780198840121.003.0005.

IEEE

P. Czobor and I. Bitter, “Pharmacologic treatment of negative symptoms: Focus on efficacy,” Oxford University Press eBooks, pp. 67–86, 2020, doi: 10.1093/med/9780198840121.003.0005.

BibTeX

@incollection{czobor2020pharmacologic,
  title     = {{Pharmacologic treatment of negative symptoms: Focus on efficacy}},
  author    = {Czobor, Pál and Bitter, István},
  booktitle = {Oxford University Press eBooks},
  publisher = {Oxford University Press},
  year      = {2020},
  pages     = {67--86},
  doi       = {10.1093/med/9780198840121.003.0005},
  url       = {https://doi.org/10.1093/med/9780198840121.003.0005}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202122
202244
202311
202511

Its field-weighted citation impact is 9.36: it has been cited 9.36 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • negative symptoms
  • schizophrenia
  • pharmacotherapy
  • atypical antipsychotics
  • typical antipsychotics
  • cariprazine
  • risperidone
  • antidepressants

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Czobor, P., & Bitter, I. (2020). Pharmacologic treatment of negative symptoms: Focus on efficacy. Oxford University Press eBooks, 67–86. https://doi.org/10.1093/med/9780198840121.003.0005

How many times has this paper been cited?

17 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Pál Czobor, István Bitter.

What is the DOI of this paper?

10.1093/med/9780198840121.003.0005, permanently at https://doi.org/10.1093/med/9780198840121.003.0005. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.